Story of the ALS-FTD continuum retold: rather two distinct entities.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
05 2019
Historique:
received: 11 05 2018
revised: 20 07 2018
accepted: 11 08 2018
pubmed: 28 9 2018
medline: 20 3 2020
entrez: 28 9 2018
Statut: ppublish

Résumé

To determine the evolution and profile of cognitive and behavioural deficits in amyotrophic lateral sclerosis (ALS) and behavioural variant frontotemporal dementia (bvFTD) to disentangle the development of FTD in ALS and vice versa. In a prospective design, cognitive and behavioural profiles of 762 patients with motor predominant ALS (flail arm/leg syndrome, primary lateral sclerosis, pseudobulbar palsy, ALS) and behavioural predominant FTD (bvFTD, ALS-FTD) were determined and caregivers of patients with ALS were asked on the evolution of behavioural symptoms. Data were compared with 49 healthy controls. Cognition was measured with the Edinburgh Cognitive and Behavioral ALS Screen. Evolution and features of cognitive profile of patients with motor predominant ALS were distinctly different from patients with behavioural FTD with regard to number and degree of affected cognitive domains. Also, in ALS mostly minus symptoms evolved after physical symptom onset whereas in ALS-FTD plus and minus symptoms were reported with an onset before physical degradation. Evolution of cognitive and behavioural profile in patients with motor predominant ALS is distinctly different from those psychocognitive findings in patients with behavioural variant dementia. This may support the hypothesis that (possibly genetic) triggers decide in the preclinical phase on either motor or psychocognitive phenotypes.

Identifiants

pubmed: 30257969
pii: jnnp-2018-318800
doi: 10.1136/jnnp-2018-318800
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

586-589

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Dorothée E Lulé (DE)

Department of Neurology, University of Ulm, Ulm, Germany dorothee.lule@uni-ulm.de.

Helena E A Aho-Özhan (HEA)

Department of Neurology, University of Ulm, Ulm, Germany.

Cynthia Vázquez (C)

Department of Neurology, University of Ulm, Ulm, Germany.

Ulrike Weiland (U)

Department of Neurology, University of Ulm, Ulm, Germany.

Jochen H Weishaupt (JH)

Department of Neurology, University of Ulm, Ulm, Germany.

Markus Otto (M)

Department of Neurology, University of Ulm, Ulm, Germany.

Sarah Anderl-Straub (S)

Department of Neurology, University of Ulm, Ulm, Germany.

Elisa Semler (E)

Department of Neurology, University of Ulm, Ulm, Germany.

Ingo Uttner (I)

Department of Neurology, University of Ulm, Ulm, Germany.

Albert C Ludolph (AC)

Department of Neurology, University of Ulm, Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH